NewsRx

Search our medical news database

Aethlon Medical, Inc.

Device has potential to treat both HIV/AIDS, Hepatitis C

Published in AIDS Weekly and Law, January 20th, 2005

Aethlon Medical, Inc., (AEMD) announced that its Hemopurifier treatment technology has demonstrated multi-pathogen clearance capabilities that could lead to a simultaneous treatment for persons infected with both HIV and the Hepatitis C virus (HCV).

The Hemopurifier is a medical device that converges the use of hollow-fiber dialysis technology with affinity chromatography to separate and selectively capture viruses and toxins from the blood. Recent enhancements to the Hemopurifier include the immobilization of a single affinity agent that is able to attach to the surface of both HIV and HCV.

Aethlon CEO James A. Joyce stated, "Our studies provide...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly and Law


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook